[Thromboembolic complications in the course of non-valvular atrial fibrillation].
Mas
J L
JL
Service de neurologie, Centre R. Garcin Hôpital Sainte-Anne, Paris.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000209:etiology / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000209:etiology* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004452:Echocardiography; D005060:Europe; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors
D005343:Fibrinolytic Agents; D010919:Placebos; D014812:Vitamin K; D001241:Aspirin
Complications thrombo-emboliques au cours de la fibrillation auriculaire non valvulaire.